Global Anti-Aging Drugs Market Trends, Forecast Report 2025-2037
Anti-Aging Drugs Market size is predicted to expand from USD 59.75 billion to USD 215.95 billion, witnessing a CAGR of over 10.3% throughout the forecast period, from 2025 to 2037. In the year 2025, the industry size of anti-aging drugs is assessed at USD 64.72 billion.
The market growth can be attributed to rising aging population around the world with the rising hope for extending the healthy lifespan of humans having youthful characteristics. According to the World Health Organization, globally, the percentage of people over 60 years of age will nearly double from 12% to 22% between 2015 and 2050.
In the prevention and treatment of age-related disorders and diseases, anti-aging drugs combine advanced biotechnology and clinical prevention medicines. Anti-aging drugs are mostly used by the baby boomer generation, as well as by consumers who care more about their health and appearance. Using these drugs, the body is able to reverse the effects of aging. The aging process is also being delayed through a wide variety of medical technologies.
Anti-Aging Drugs Sector: Growth Drivers and Challenges
Growth Drivers
- Growing Prevalence of Photoaging Among People - premature aging of the skin is caused by sun exposure. Skin damage caused by the sun is referred to by a number of names in dermatology, including photoaging. Certainly, UV exposure causes more visible signs of facial aging. Thus, the rising cases of photoaging are expected to propel the demand for anti-aging drugs during the forecast period. It was observed that, approximately 90% of European and North American adults with skin phototypes I, II, and III show clinically detectable photoaging.
- An Increasing Number of Dermatologists - for instance, nearly 3,700 dermatologists are presently employed in the United States. Women account for over 85% of dermatologists, while men account for 14%.
- Rising Personal Disposable Income - according to the Bureau of Economic Analysis, in July 2022 disposable personal income (DPI) increased by USD 37.6 billion (0.2%) in United States.
- Increasing Level of Chronic Stress Among People- it was observed that globally, approximately 33% of people admitted feeling stressed.
- Excessive Alcohol Consumption – according to the Centers for Diseases Control and Prevention, nearly 16% of adults are excessive alcohol drinkers, and 6% are reported, as heavy drinkers.
Challenges
- High Cost of Anti-Aging Drugs - medical research and funding is vital and central for the development of aging-related medications. With huge funds invested in the scientific research and development of these drugs, it is still unaffordable for many.
- Low Awareness of Anti-Aging Drugs in Low-Income Countries
- Presence of Alternatives in the Market
Anti-Aging Drugs Market: Key Insights
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
10.3% |
|
Base Year Market Size (2024) |
USD 59.75 billion |
|
Forecast Year Market Size (2037) |
USD 215.95 billion |
|
Regional Scope |
|
Anti-Aging Drugs Segmentation
Type (Dermal Fillers, Botulinum Toxin)
The dermal fillers segment is anticipated to capture the largest anti-aging drugs market share by 2037, owing to increasing dermal filler injections and higher adoption of derma fillers in treating wrinkles and fine lines. For instance, it was found that in 2018, there were approximately 2.6 million dermal filler injections in America.
Our in-depth analysis of the global anti aging drugs market includes the following segments:
|
By Type |
|
|
By Drug Class |
|
|
By Application |
|
|
By Distribution Channel |
|
Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.
Customize this ReportAnti-Aging Drugs Industry - Regional Synopsis
North America Market Forecast
The North America anti-aging drugs market is expected to account for largest revenue share by the end of 2037, backed by increasing number of non-invasive cosmetic treatments, the growing demand for anti-aging products, and the rapid expansion of the personal care industry. For instance, in 2020 nearly 13,280,000 cosmetic minimally invasive surgery procedures were carried out in the United States.
Companies Dominating the Anti-Aging Drugs Landscape
- L’Oreal SA
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Merz Pharma GmbH & Co.
- Novartis AG
- BioTime Inc.
- ARK Skincare
- Elysium Health Inc.
- Estee Lauder Inc.
- DermaFix
- Bayer Pharma AG
- La Roche-Posay
In the News
-
L'Oréal SA has acquired Skinbetter Science, an American skin care brand provided by a doctor, owing to state-of-the-art dermatological science, combining patented effective ingredients with luxurious sensory textures.
-
Merz Pharma GmbH & Co., officially announced the opening of its latest filler plant in BioPharmaPark, Dessau-Rosslau, Germany.
Author Credits: Radhika Pawar
- Report ID: 375
- Published Date: Jan 17, 2025
- Report Format: PDF, PPT
